The use of selective serotonin reuptake inhibitors in autism and related disorders.

@article{Posey2006TheUO,
  title={The use of selective serotonin reuptake inhibitors in autism and related disorders.},
  author={David J. Posey and Craig A. Erickson and Kimberly Ann Stigler and Christopher J. McDougle},
  journal={Journal of child and adolescent psychopharmacology},
  year={2006},
  volume={16 1-2},
  pages={181-6}
}
This paper reviews the published literature on the use of selective serotonin reuptake inhibitors (SSRIs) for the treatment of symptoms associated with autistic disorder and other pervasive developmental disorders (PDDs) in both children and adults. To date, placebocontrolled studies of SSRIs have involved only fluvoxamine (in children and adults) and fluoxetine (in children). Open-label and retrospective studies of all other SSRIs in PDDs have also been published that suggest effectiveness… CONTINUE READING